´
C. Saintome et al. / Tetrahedron 56 (2000) 1197–1206
1204
100
described in the general procedure. Purification of the reac-
tion product by flash chromatography (EtOH/CH2Cl2, 8:92,
1% TEA) gave 15a (144 mg, 77% yield) as a foam. 1H NMR
(300 MHz, CDCl3), d (ppm): 7.87 (br s, 1H, NH amide),
CH2 POM), 4.55 (s, 2H, N –CH2), 4.44 (m, 1H, H30), 4.06
(m, 1H, H40), 3.76 (s, 6H, OCH3 DMT), 3.50–3.00 (m, 6H,
H50; H500; 2 H8; 2 H9), 2.37 (m, 2H, H20; H200), 1.99 (s, 3H,
CH3), 1.15 (s, 9H, CH3 POM). 13C NMR (62 MHz, CDCl3),
d (ppm): 179.0 (C400), 176.7 (CyO POM), 168.1 (CyO
amide), 161.4 (C4), 159.2 (quat DMT), 155.3 (C200), 149.5
(C2), 145.5 (C600), 145.1 (quat DMT), 136.2 (quat DMT),
136.1 (quat DMT), 130.8 (ar DMT), 128.8 (ar DMT), 128.6
(ar DMT), 127.7 (ar DMT), 126.0 (C5), 113.8 (ar DMT),
113.0 (C500), 111.6 (C6), 87.0 (quat DMT), 86.5 (C40), 85.2
(C10), 72.7 (C30), 64.5 (C50), 61.3 (CH2 POM), 55.9 (OCH3
7.55ء
(s, 1H, H6), 7.45–7.15 (m, 10H, H600 ; ar DMT), 7.03
(br s, 1H, NH amide), 6.83 (d, 4H, ar DMT, J8.7 Hz), 6.34
(t, 1H, H10, J6.6 Hz), 5.77 (s, 2H, CH2 POM), 4.54 (m,
00
3H, H30; N1 –CH2), 4.06 (m, 1H, H40), 3.77 (s, 6H, OCH3
DMT), 3.45–3.26 (m, 6H, H50; H500; 2 H11; 2 H12), 2.50–
2.14 (m, 6H, H20; H200; 2 H7 and 2 H8), 1.98 (s, 3H, CH3),
1.16 (s, 9H, CH3 POM). 13C NMR (62 MHz, CDCl3), d
(ppm): 179.0 (C400), 176.7 (CyO POM), 173.6 (C9), 167.7
(CyO amide), 165.0 (C4), 159.3 (quat DMT), 155.3 (C200),
151.3 (C2), 145.3 and 145.1 (C600 and quat DMT), 138.0
(C6), 136.2 (quat DMT), 130.8 (ar DMT), 128.8 (ar DMT),
100
DMT), 53.9 (N –CH2), 40.6 (C20 ), 39.5 (C8; C9; C(CH3)3
POMء
), 14.4 (CH3). FABϩ-MS: m/z 303 (DMT); 653
(MϩNaϪ255ϩ1)ϩ; 675 (MϪHϩ2NaϪ255ϩ1)ϩ, 789
(MϩNaϪ119ϩ1)ϩ, 907 (MϩNa)ϩ.
128.6 (ar DMT), 127.7 (ar DMT), 114.4 (C500 ), 113.9 (ar
DMT), 113.0 (C5ء
), 87.4 (quat DMT), 86.8 (C40), 85.6
(C10), 72.8 (C30), 64.5 (C50), 61.4 (CH2 POM), 55.9
50-O-[4,40-Dimethoxytrityl]-5-[3-[(S-pivaloyloxymethyl-
4-thiothymin-1-ylacetyl)amino]prop-1-yn-1-yl]-20-deoxy-
uridine 17. To a solution of 50-O-(4,40-dimethoxytrityl)-5-
iodo-20-deoxyuridine 916 (374 mg, 0.57 mmol) in DMF
(4 mL) was added CuI (26 mg, 0.24 equiv.), Et3N
(150 mL, 2 equiv.) and compound 14 (400 mg, 2 equiv.).
The reaction was degassed then purged under argon and
(Ph3P)4Pd(0) (80 mg, 0.12 equiv.) was added and the
reaction again purged with argon and stirred for 6.5 h. The
reaction was concentrated, diluted with ethyl acetate
(50 mL) and the organic phase washed with 3×25 mL of a
saturated hydrogen carbonate solution and dried over
sodium sulfate. Then it was concentrated and the residue
chromatographed on silica gel column eluting with a
gradient of 0–10% of methanol in CH2Cl2 to afford 17
(223 mg, 44% yield) as a foam. 1H NMR (300 MHz,
DMSO-d6), d (ppm): 11.82 (s, 1H, N3-H), 8.85 (t, 1H,
NH amide, J4.8 Hz), 8.08 (s, 1H, H600), 7.94 (s, 1H,
H6), 7.64–7.31 (m, 9H, ar DMT), 7.02 (d, 4H, ar DMT,
J8.3 Hz), 6.24 (t, 1H, H10, J6.5 Hz), 5.88 (s, 2H, CH2
100
(OCH3 DMT), 53.2 (N -CH2), 41.4 (C20), 40.4–39.5 and
39.4 (C(CH3)3 POM; C11 and C12), 36.3 (C8), 27.6
(C(CH3)3 POM), 23.7 (C7), 14.4 (CH3). FABϩ-MS: m/z
303 (DMT), 653 (MϩNaϪ312ϩ1)ϩ, 675 (MϪ1ϩ2NaϪ
312ϩ1)ϩ, 963 (MϩNa)ϩ.
50-O-[4,40-Dimethoxytrityl]-5-[3-[[4-[(S-pivaloyloxy-
methyl-4-thiothymin-1-ylacetyl)amino]butyl]amino]-3-
oxopropyl]-20-deoxyuridine 15b. Nucleoside 12b (500 mg,
74 mmol) was treated with 13 as described in the general
procedure. Purification of the reaction product by flash
chromatography (MeOH/CH2Cl2, 6:94, 1% TEA), gave
1
15b (240 mg, 34% yield) as a foam. H NMR (300 MHz,
CDCl3), d (ppm): 7.72 (br s, 1H, NH amide), 7.51 (s, 1H,
H600 ), 7.46–7.14 (m, 10H, H6ء
; ar DMT), 6.83 (d, 4H, ar
DMT, J8.5 Hz), 6.56 (br s,1H, NH amide), 6.37 (t, 1H,
100
H10, J6.6 Hz), 5.78 (s, 2H, CH2 POM), 4.52 (m, 3H, N –
CH2 and H30), 4.08 (m, 1H, H40), 3.76 (s, 6H, OCH3 DMT),
3.43–3.06 (m, 6H, 2 H11; 2 H14; H50 and H500), 2.50–2.10
(m, 6H, H20; H200; 2 H7 and 2 H8), 1.99 (s, 3H, CH3), 1.60–
100
POM), 5.47 (d, 1H, OH 20, J4.3 Hz), 4.57 (s, 2H, N –
CH2), 4.39 (m, 1H, H30), 4.06 (m, 3H, H40; 2 H9), 3.84 (s,
6H, OCH3 DMT), 3.38 (dd, 1H, H50, J10.2, 5.3 Hz), 3.20
(br d, 1H, H500, J10.2 Hz), 2.35 (m, 2H, H20;H200), 2.05 (s,
3H, CH3), 1.24 (s, 9H, CH3 POM). 13C NMR (75 MHz,
DMSO-d6), d (ppm): 177.5 (C400), 173.7 (CyO POM),
166.3 (CyO amide), 161.7 (C4), 158.2 (quat DMT), 153.2
(C200), 149.5 (C2), 146.8 (C600), 145.0 (quat DMT), 143.7
(C6), 135.8 (quat DMT), 135.4 (quat DMT), 129.8 (ar
DMT), 128.0 (ar DMT), 127.7 (ar DMT), 126.8 (ar
DMT), 113.4 (ar DMT), 109.8 (C500), 98.3 (C5), 89.0
(C7), 86.0 (quat DMT; C40), 85.2 (C10), 74.7 (C8), 70.6
(C30), 63.9 (C50), 60.8 (CH2 POM), 55.2 (OCH3 DMT),
1.34 (m, 4H, 2 H12 and 2 H13), 1,16 (s, 9H, CH3 POM). 13
C
NMR (75 MHz, CDCl3), d (ppm): 179.0 (C400), 176.4 (CyO
POM), 172.8 (C9), 167.3 (CyO amide), 164.7 (C4), 159.1
(quat DMT), 155.2 (C200), 151.3 (C2), 145.4 (C600), 145.1
(quat DMT), 137.8 (C6), 136.1 (quat DMT), 130.6 (ar
DMT), 128.7 (ar DMT), 128.5 (ar DMT), 127.5 (ar
DMT), 114.0 (C5ء
), 113.8 (ar DMT), 112.8 (C500 ), 87.1
(quat DMT), 86.6 (C40), 85.3 (C10), 72.4 (C30), 64.4
100
(C50), 61.3 (CH2 POM), 55.8 (OCH3 DMT), 53.1 (N –
CH2), 41.0 (C20), 39.9; 39.4; 39.3 (C11; C12; C(CH3)3
POM), 35.6 (C8), 27.4 (C(CH3)3 POM), 27.1 and 26.8
(C12 and C13), 23.9 (C7), 14.2 (CH3). FABϩ-MS: m/z
303 (DMT), 681 (MϩNaϪ312ϩ1)ϩ, 703 (MϪ1ϩ2NaϪ
312ϩ1)ϩ, 991 (MϩNa)ϩ.
100
51.4 (N –CH2), 40.0 (C20), 38.3 (C(CH3)3POM), 29.0
(C9), 26.7 (C(CH3)3POM), 13.2 (CH3). FABϩ-MS: m/z
902, (MϩNa)ϩ.
50-O-[4,40-Dimethoxytrityl]-5-[[2-[(S-pivaloyloxy-
methyl-4-thiothymin-1-ylacetyl)amino]ethyl]amino]-20-
deoxyuridine 16. Nucleoside 10 (74 mg, 0.13 mmol) was
treated with 13 as described in the general procedure. Puri-
fication of the reaction product by flash chromatography
(MeOH/CH2Cl2, 0–5%, 1% TEA), gave nucleoside 16
(60 mg, 54% yield) as a foam. 1H NMR (250 MHz,
CDCl3), d (ppm): 7.64 (br s, 1H, NH amide), 7.50–7.10
(m, 10H, H600; ar DMT), 6.81 (d, 4H, ar DMT, J7.2 Hz),
6.52 (s, 1H, H6), 6.46 (t, 1H, H10, J6.6 Hz), 5.78 (s, 2H,
Preparation of phosphoramidites 18a, 18b, 19, 20. To a
solution of each nucleoside (15a, 15b, 16 and 17) in CH2Cl2
(8.9 mL/mmol) under argon, was added N,N-diisopropyl-
ethylamine (4 equiv.) and 2-cyanoethyl N,N-diisopropyl-
chloro-phosphoramidite (3 equiv.). Upon completion of
the reaction, the mixtures were concentrated and the
residues dissolved in CH2Cl2. The solutions were washed
with sodium hydrogen carbonate, dried over sodium
sulfate and the desired products (18a, 18b, 19 and 20)
characterized. 31P NMR (121.49 MHz, CDCl3): d ppm